NCT05256836

Brief Summary

To evaluate the effectiveness of tablet computer-based cognitive training in patients with idiopathic REM sleep behavior disorder.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

February 7, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

1.5 years

First QC Date

February 6, 2022

Last Update Submit

April 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K) total score

    Z score of total 5 domains (attentive, memory, language, visuospatial and executive functions)

    Change from baseline CERAD-K total score at 12 weeks

Secondary Outcomes (13)

  • Change in CERAD-K attention score

    Change from baseline CERAD-K attention score at 12 weeks

  • Change in CERAD-K memory score

    Change from baseline CERAD-K memory score at 12 weeks

  • Change in CERAD-K language score

    Change from baseline CERAD-K language score at 12 weeks

  • Change in CERAD-K visuospatial function score

    Change from baseline CERAD-K visualspatial function score at 12 weeks

  • Change in CERAD-K executive function score

    Change from baseline CERAD-K executive function score at 12 weeks

  • +8 more secondary outcomes

Study Arms (2)

tablet group

EXPERIMENTAL

A total of 36 sessions per week for 12 weeks of cognitive training program using a tablet computer are performed.

Other: Tablet computer-based cognitive training program

control group

NO INTERVENTION

Subjects assigned to the control group did not receive any separate cognitive training for 12 weeks.

Interventions

The subject of the study executes a program mounted on a tablet personal computer (PC) (Samsung Galaxy Tab S6 Lite) and performs a cognitive training task by touching the screen with the index finger. It consists of 10 tasks related to the activity of daily living: 1) taking medicine, 2) making a phone call, 3) taking a shower, 4) doing laundry, 5) finding directions, 6) riding the bus, 7) buying goods, 8) Money management, 9) ingredient sorting, 10) meal preparation. It is involved in cognitive functions in various domains such as attention, working memory, processing speed, problem solving, visuospatial ability, verbal and visuospatial memory. There are three levels of difficulty for each task, high, medium, and low, and the difficulty becomes more difficult as session 1 to 36 progresses. One cognitive training session lasts about 30 minutes.

tablet group

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 60-80 years old who have been diagnosed with iRBD through nocturnal polysomnography according to the International Classification of Sleep Disorders 3rd Edition (ICSD-3) diagnostic criteria
  • Those who gave their written consent to participate in the study

You may not qualify if:

  • Patients with neurodegenerative diseases including Parkinson's disease, dementia, and multiple system atrophy
  • Patients with secondary causes of RBD
  • Patients with severe hearing, visual impairment, or motor impairment
  • Patients who have received cognitive training within the last year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

REM Sleep Behavior Disorder

Condition Hierarchy (Ancestors)

REM Sleep ParasomniasParasomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Ki-Young Jung, professor

    Seoul National University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2022

First Posted

February 25, 2022

Study Start

February 7, 2022

Primary Completion

August 1, 2023

Study Completion

December 1, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Locations